Private Management Group Inc. Has $30.66 Million Stake in Avantor, Inc. $AVTR

Private Management Group Inc. boosted its holdings in Avantor, Inc. (NYSE:AVTR) by 13.3% in the second quarter, Holdings Channel reports. The firm owned 3,097,234 shares of the company’s stock after purchasing an additional 364,239 shares during the quarter. Private Management Group Inc.’s holdings in Avantor were worth $30,663,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Avantor by 28.1% during the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after buying an additional 905 shares in the last quarter. Osaic Holdings Inc. boosted its stake in shares of Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Avantor by 17.6% in the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock valued at $84,000 after acquiring an additional 1,101 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares in the last quarter. Finally, Public Employees Retirement System of Ohio increased its position in shares of Avantor by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 206,386 shares of the company’s stock valued at $2,576,000 after acquiring an additional 1,279 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Stock Down 0.1%

Avantor stock opened at $14.60 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18. The company’s 50-day moving average is $12.12 and its 200-day moving average is $9.77. The firm has a market capitalization of $9.87 billion, a PE ratio of -17.38, a P/E/G ratio of 11.00 and a beta of 0.89. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same period last year, the business posted $0.24 EPS. Avantor’s revenue was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Sell-side analysts anticipate that Avantor, Inc. will post 0.81 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Barclays upped their target price on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, June 24th. Evercore set a $10.50 price target on Avantor in a research note on Monday, July 6th. Wolfe Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 30th. UBS Group set a $8.00 price objective on Avantor in a research note on Wednesday, June 24th. Finally, Morgan Stanley increased their price objective on Avantor from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Two research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Avantor currently has an average rating of “Hold” and an average target price of $12.00.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.